Valproic Acid Capsule, Liquid Filled
Product Images NDC 70518-0079

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Valproic Acid (NDC 70518-0079). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Valproic Acid is a medication that comes in capsule form with a strength of 250 mg. The bottle contains 30 capsules and it is prescribed only. The manufacturer of the medication is Bianpharma Inc, located in Princeton, New Jersey. The medication should be stored at a temperature of 20-25°C (68-77°F) with permissible excursions ranging from 15-30°C (59-86°F). The medication should be kept out of children's reach. The packaging firm is RemedyRepackInc situated in Indiana, Pennsylvania. The instructional manual should be checked for usage directions.*

FDA Label Image

Mm2 (Valproic Acid 250mg 70518 0079 01)

This is a prescription drug named Valproic Acid, manufactured by Bionpharma Inc. in 250 mg capsules, packaged by RemedyRepack Inc. as a quantity of 100 HD3 capsules. The National Drug Code (NDC) number is 70518-0079-01 and the original source NDC is 69452-0150-20. The expiration date is not available in the given text. The drug should be stored between 20-25°C (68-77°F) and kept out of reach of children. The package insert should be referred to for usage instructions.*

FDA Label Image

Mm3 (Valproic Acid 250mg 70518 0079 02)

Valproic Acid is a prescription medication provided in capsule form by Bianpharma Inc., Princeton, NJ 08540 with a strength of 250mg. The medication must be stored between 20-25°C (63-77°F) and must be kept out of the reach of children. The package insert contains the directions for use. The medication has been repackaged by RemedyRepark Inc., Indiana, PA 15701.*

FDA Label Image

Undefined (Image 00001)

FDA Label Image

Undefined (Image 00002)

The text "50% Reduction In CPS Rate" indicates that there has been a 50% reduction in CPS (Presumably, Clinical Payment Systems) rate for an unspecified population. The text appears to be incomplete and lacks more context, therefore no further information can be obtained.*

FDA Label Image

Undefined (Image 00003)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.